These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3278832)

  • 21. Comparison of cholesterol-lowering regimens.
    Snyder S
    Am Fam Physician; 1990 Sep; 42(3):761-8. PubMed ID: 2168121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol homeostasis in mononuclear leukocytes from patients with familial hypercholesterolemia treated with lovastatin.
    Hagemenas FC; Illingworth DR
    Arteriosclerosis; 1989; 9(3):355-61. PubMed ID: 2719596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simvastatin: a review of its pharmacology and clinical use.
    Mauro VF; MacDonald JL
    DICP; 1991 Mar; 25(3):257-64. PubMed ID: 2028634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR; Bacon S
    Metabolism; 1989 Jun; 38(6):542-9. PubMed ID: 2725293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study.
    Havel RJ; Hunninghake DB; Illingworth DR; Lees RS; Stein EA; Tobert JA; Bacon SR; Bolognese JA; Frost PH; Lamkin GE
    Ann Intern Med; 1987 Nov; 107(5):609-15. PubMed ID: 3662274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lovastatin: an HMG-CoA reductase inhibitor for lowering cholesterol.
    Frishman WH; Rapier RC
    Med Clin North Am; 1989 Mar; 73(2):437-48. PubMed ID: 2645482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug treatment of dyslipoproteinemia.
    Hunninghake DB
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):345-60. PubMed ID: 2192877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.
    Tobert JA; Bell GD; Birtwell J; James I; Kukovetz WR; Pryor JS; Buntinx A; Holmes IB; Chao YS; Bolognese JA
    J Clin Invest; 1982 Apr; 69(4):913-9. PubMed ID: 6918402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery, biochemistry and biology of lovastatin.
    Alberts AW
    Am J Cardiol; 1988 Nov; 62(15):10J-15J. PubMed ID: 3055919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and long-term adverse effect pattern of lovastatin.
    Tobert JA
    Am J Cardiol; 1988 Nov; 62(15):28J-34J. PubMed ID: 3055921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II.
    JAMA; 1986 Nov; 256(20):2829-34. PubMed ID: 3534333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Statins in hypercholesterolemia treatment].
    Quintão EC
    Rev Assoc Med Bras (1992); 1994; 40(1):50-8. PubMed ID: 8061697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term administration of lovastatin in the treatment of hypercholesterolaemia.
    Illingworth DR
    Eur Heart J; 1987 Aug; 8 Suppl E():103-11. PubMed ID: 3678268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbial production and biomedical applications of lovastatin.
    Seenivasan A; Subhagar S; Aravindan R; Viruthagiri T
    Indian J Pharm Sci; 2008 Nov; 70(6):701-9. PubMed ID: 21369428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lovastatin therapy for cholesterol ester storage disease in two sisters.
    Tarantino MD; McNamara DJ; Granstrom P; Ellefson RD; Unger EC; Udall JN
    J Pediatr; 1991 Jan; 118(1):131-5. PubMed ID: 1986080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low density lipoprotein receptor regulation and the cellular basis of atherosclerosis: implications for nutritional and pharmacologic treatment of hypercholesterolemia.
    Heber D; Koziol BJ; Henson LC
    Am J Cardiol; 1987 Oct; 60(12):4G-8G. PubMed ID: 3314448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term effects of lovastatin therapy on proteinuria of type 2 diabetic nephropathy: A clinical trial study.
    Sadighi A; Safa J; Vatankhah AM; Ghorashi S; Aharilahagh A; Davari-Farid S; Nezami-Nargabad O; Naghavi-Behzad M; Piri R; Pishahang P; Babapoor-Farrokhran S; Fakour S; Ghodratnezhad-Azar N
    Niger Med J; 2016; 57(5):253-259. PubMed ID: 27833243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A symposium: HMG CoA reductase inhibitors--a new therapeutic class. Atlanta, Georgia, March 26, 1988. Proceedings.
    Am J Cardiol; 1988 Nov; 62(15):1J-49J. PubMed ID: 2903658
    [No Abstract]   [Full Text] [Related]  

  • 39. Lifibrol: first member of a new class of lipid-lowering drugs?
    Scharnagl H; März W; Wieland H
    Expert Opin Investig Drugs; 1997 May; 6(5):583-91. PubMed ID: 15989622
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.